Detection of Streptococcus gallolyticus in colorectal cancer and inflammatory bowel disease patients compared to control
- PDF / 669,845 Bytes
- 5 Pages / 595.276 x 790.866 pts Page_size
- 52 Downloads / 167 Views
ORIGINAL ARTICLE
Detection of Streptococcus gallolyticus in colorectal cancer and inflammatory bowel disease patients compared to control group in southwest of Iran Ahmad Farajzadeh Sheikh1,2 · Abdol Rahim Masjedi Zadeh3 · Morteza Saki1,4 · Parisa Khani1 · Seyed Jalal Hashemi5 · Sam Shahin Zadeh5 · Maryam Dastoorpoor6 Received: 31 May 2020 / Accepted: 3 September 2020 © Springer Nature B.V. 2020
Abstract There are several pieces of evidence regarding the role of bacteria, such as Streptococcus bovis/gallolyticus in the etiology of gastrointestinal diseases such as colorectal cancer (CRC) and inflammatory bowel disease (IBD). Therefore, the aim of this study was to detect S. gallolyticus subsp. gallolyticus (Sgg) in fecal samples of CRC and IBD patients by culture and molecular methods, in Ahvaz, southwest of Iran. A total of 106 fecal samples were collected from 22 CRC patients, 44 IBD patients, and 40 healthy individuals. The prevalence of Sgg was investigated by culture and polymerase chain reaction (PCR) with specific primers for sodA gene. The results of the stool culture showed that the overall prevalence of Sgg was 9 (13.6%) out of 66 patients. Meanwhile, the number of Sgg isolated from IBD and CRC patients was 7 (15.9%) and 2 (9%), respectively. The bacteria were not isolated from any of the control groups. On the basis of PCR, S. gallolyticus was detected in 24 (36.4%) out of 66 patients. Meanwhile, the number of IBD patients with positive sodA gene was 15 (34.1%) out of 44 cases. In CRC patients, the sodA gene was detected in 9 (40.9%) of 22 cases. Two (5%) of the specimens in the control group had the sodA gene. According to our results, S. gallolyticus subsp. gallolyticus might be involved in CRC and IBD pathogenesis. More investigation with different samples in the various areas might be shaded light on these results. Keywords Colorectal cancer · Streptococcus gallolyticus · Inflammatory bowel disease · Iran
Introduction
* Parisa Khani 1
Department of Microbiology, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
2
Atherosclerosis Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
3
Alimentary Tract Research Center, Department of Gastroenterology, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
4
Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
5
Alimentary Tract Research Center, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
6
Department of Biostatistics and Epidemiology, Menopause Andropause Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
Today, the spread of gastrointestinal (GI) disorders, such as inflammatory bowel disease (IBD) and colorectal cancer (CRC) is increasing worldwide. Patients with IBD are further inclined to the development of CRC [1, 2]. Among all cancer types, the CRC is the second frequent cancer and the fourth cause of death all over the world [3
Data Loading...
